Onconetix, Inc., a pharmaceutical company with a market capitalization of just $3.98 million, has received a notification from The Nasdaq Stock Market LLC indicating non-compliance with the minimum ...
Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6 ...
Onconetix, Inc., a pharmaceutical company with a market capitalization of just $3.98 million, has received a notification from The Nasdaq Stock Market LLC indicating non-compliance with the ...
EST Onconetix (ONCO) files to sell 50M shares of common stock for holdersInvest with Confidence: Follow TipRanks' Top Wall Street ...
Onconetix, Inc. (NASDAQ:ONCO), a pharmaceutical company with a market capitalization of $4.48 million, has reached a settlement agreement with IQVIA, Inc., a provider of advanced analytics ...
Cincinnati, OH, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6, 2024 ...
Onconetix, Inc. (NASDAQ:ONCO), a pharmaceutical company with a market capitalization of $4.48 million, has reached a settlement agreement with IQVIA, Inc., a provider of advanced analytics, technology ...
Onconetix, Inc. (NASDAQ: ONCO) (the “Company”) announced that it received a letter from The Nasdaq Capital Market (“Nasdaq”) on December 6, 2024 indicating that the Company’s failure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback